Aggression and Agitation in Dementia

Continuum : Lifelong Learning in Neurology
M Uri WolfMorris Freedman

Abstract

This article reviews the treatment of aggression and agitation in dementia. Both nonpharmacologic and pharmacologic approaches to responsive behaviors are discussed. Practical treatment strategies are applied to common behavioral symptoms. Aggressive and agitated behavior is common in dementia. Behavioral symptoms lead to reduced quality of life and distress for both patients and caregivers. They can also lead to poor outcomes and are associated with significant financial implications for the individual and health care system. A wide range of difficult behaviors exists, with limited evidence for deciding on treatment. Clinicians should integrate the available evidence with practical and commonsense strategies to target these difficult-to-treat behaviors. Treating aggression and agitation in dementia is challenging. Viewing behaviors as a response to either internal or external stimuli can help guide treatment. Treatment should emphasize nonpharmacologic approaches as an initial step, using practical and commonsense strategies. Caregivers and family should be actively involved in the planning and implementation of behavioral plans. It is essential to minimize both medical and nonmedical factors that may be contributing to behavi...Continue Reading

References

Jan 1, 1992·International Psychogeriatrics·J Cohen-MansfieldP Werner
Oct 1, 1992·Journal of Geriatric Psychiatry and Neurology·R FriedmanM Freedman
Jan 1, 1989·International Psychogeriatrics·J Cohen-MansfieldM S Marx
May 1, 1989·Journal of Gerontology·J Cohen-MansfieldA S Rosenthal
Oct 1, 1986·Journal of the American Geriatrics Society·J Cohen-Mansfield, N Billig
Nov 23, 2000·Neurology·L TeriUNKNOWN Alzheimer's Disease Cooperative Study
Oct 19, 2001·CNS Drug Reviews·S A Anttila, E V Leinonen
Dec 12, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·J Cohen-Mansfield
Dec 18, 2001·International Journal of Geriatric Psychiatry·C G LyketsosJ C Breitner
Nov 29, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Brian Lawlor
Jan 13, 2004·International Journal of Geriatric Psychiatry·Marjolein E de VugtFrans R J Verhey
Apr 20, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·P PollakI Bourdeix
Aug 16, 2005·Journal of Geriatric Psychiatry and Neurology·Benjamin BlackRajesh R Tampi
Oct 12, 2005·Current Psychiatry Reports·Tiffany W Chow
Nov 26, 2005·Primary Care Companion to the Journal of Clinical Psychiatry·Rebecca W Brendel, Theodore A Stern
Nov 30, 2005·International Journal of Geriatric Psychiatry·Ajit ShahTade Thompson
Mar 1, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Lon S SchneiderPhilip S Insel
Oct 19, 2006·The Annals of Pharmacotherapy·Asha L Tata, Denise R Kockler
Aug 19, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Jiska Cohen-MansfieldMarcia S Marx
Dec 20, 2007·Alzheimer Disease and Associated Disorders·Jennifer Merrilees
Sep 4, 2008·Psychological Reports·Catherine A Yeager, Lee Hyer
Apr 7, 2010·The Journal of Clinical Psychiatry·Mark E KunikRobert O Morgan
Sep 6, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Constantine G LyketsosDavid S Miller
Jan 11, 2012·Neurocase·Nuria Gil-RuizUNKNOWN Alzheimer Center Of The Queen Sofia Foundation Multidisciplinary Therapy Group
Apr 21, 2012·American Journal of Alzheimer's Disease and Other Dementias·Govind BharwaniMeena Bharwani
Aug 16, 2012·Alzheimer Disease and Associated Disorders·Julio C FurlanMorris Freedman
Sep 7, 2012·The American Journal of Psychiatry·Martin Steinberg, Constantine G Lyketsos
Nov 22, 2012·JAMA : the Journal of the American Medical Association·Laura N GitlinConstantine G Lyketsos
Apr 3, 2013·Journal of the American Medical Directors Association·Hayley RobinsonElizabeth Broadbent
Apr 5, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Shunichiro ShinagawaKazuhiko Nakayama
Sep 12, 2013·The Journal of Clinical Psychiatry·Paul B Rosenberg ADMET Investigators
Mar 4, 2015·BMJ : British Medical Journal·Helen C KalesConstantine G Lyketsos
Apr 2, 2016·The American Journal of Psychiatry·Anne K LeonpacherUNKNOWN CitAD Research Group

❮ Previous
Next ❯

Citations

May 4, 2021·Frontiers in Neurology·Claudia CarrariniLaura Bonanni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Medical Directors Association
Gwendolen T Buhr, Heidi K White
Journal of the American Medical Directors Association
Gwendolen T Buhr, Heidi K White
The Journal of the American Osteopathic Association
F A Komara
© 2022 Meta ULC. All rights reserved